INSIGHTS ON CLINICAL TRIAL DESIGN

• How AI Can Accelerate Clinical Trial And Registry Builds

  AI tools speed study design — from protocol creation to validation and analysis — by automating complex tasks and generating intelligent data while preserving control, accuracy, and flexibility.

• A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity

  The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

• Challenges To Making Go/No-Go Decisions In Clinical Trials

  In drug development, a go/no-go decision can be a high-stakes trade-off between speed and certainty. Delve into the real-world operational and strategic hurdles to making those decisions.

• Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study

  This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

• Human-Centered RTSM Design Enhances Data, Safety, And Operations

  12/5/2025

  Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.

• When Your Protocol Includes Ocular Endpoints

  4/6/2026

  Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.

• SCOPE 2026 In The Rear-View Mirror

  2/18/2026

  Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.

• Are Your Clinical Study Meetings Building Momentum, Or Wasting Time?

  9/17/2025

  Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.

• Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

  9/25/2025

  The benefits are clear: CRM accelerates dose finding, reduces patient exposure to unsafe doses, and improves trial efficiency.